Guidelines for Submitting Adverse Event Reports for Publication
Thérapie, 64 4 (2009) 289-294
Publié en ligne : 2009-10-07
Article cité par
La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).
Article cité :
Citations de cet article :
Postmarketing Surveillance: Review of Open Sources of Drug Safety Data
E. V. ShubnikovaSafety and Risk of Pharmacotherapy 12 (3) 309 (2024)
https://doi.org/10.30895/2312-7821-2024-12-3-309-330
CaReL Guidelines: A Consensus-Based Guideline on Case Reports and Literature Review (CaReL)
Sakshi Prasad, Mahmoud Nassar, Ahmed Y. Azzam, Francisco García-Muro-San José, Mahnaz Jamee, Rim Kasem Ali Sliman, Giuseppe Evola, Ayman M. Mustafa, Hiwa O. Abdullah, Berun A. Abdalla, Shvan H. Mohammed, Fahmi H. Kakamad, Abdulwahid M. Salih, Nicola Tartaglia, Giovanna Pavone, Giuliano D’Onghia, Silviu Daniel Preda, Sofia Maraki, Ivona Butorac Ahel, Carlo Pietro Campobasso, Jacek K. Szymański, Andrea Bottari, Laura Fortuna, Stefano Giuseppe Caraffi, Ilaria Mormile, et al.Barw Medical Journal (2024)
https://doi.org/10.58742/bmj.v2i2.89
Materiovigilance: An Overview
Shaik Nikhath Faheem and Zeba SultanaInternational Journal of Innovative Science and Research Technology (IJISRT) 3646 (2024)
https://doi.org/10.38124/ijisrt/IJISRT24MAY509
Evaluation of a simplified pharmacovigilance tool for general practitioners: 5 years of insight
A. Trenque, A. Rabiaza, S. Fedrizzi, B. Chretien, M. Sassier, R. Morello, J. Alexandre and X. HumbertScientific Reports 14 (1) (2024)
https://doi.org/10.1038/s41598-024-51753-w
Materiovigilance in Perspective: Understanding Its Concept and Practice in the Global Healthcare System
Binaya Sapkota, Subish Palaian, Sunil Shrestha and Mohamed Izham Mohamed IbrahimTherapeutic Innovation & Regulatory Science 57 (4) 886 (2023)
https://doi.org/10.1007/s43441-023-00514-4
c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children – A c4c expert group white paper
Beate Aurich, Dina Apele‐Freimane, Tobias Banaschewski, Laurent Chouchana, Simon Day, Florentia Kaguelidou, Lauren E. Kelly, Jenny M. Kindblom, Antje Neubert and Ian C. K. WongBritish Journal of Clinical Pharmacology 88 (12) 4997 (2022)
https://doi.org/10.1111/bcp.15119
The challenge of detecting adverse events in adults with autism spectrum disorder who have intellectual disability
Pura Ballester, Cristina Espadas, Ana C. Londoño, Susana Almenara, Victor Aguilar, Cesar Belda, Enrique Pérez, Javier Muriel and Ana M. PeiróAutism Research 15 (1) 192 (2022)
https://doi.org/10.1002/aur.2624
Analysis of completeness for spontaneous reporting of disease-modifying therapies in multiple sclerosis
Ariane G. S. Araujo, Rosa C. Lucchetta, Fernanda S. Tonin, Roberto Pontarolo, Helena H. L. Borba and Astrid WiensExpert Opinion on Drug Safety 20 (6) 735 (2021)
https://doi.org/10.1080/14740338.2021.1897566
Gender based differences, pharmacogenetics and adverse events in chronic pain management
Beatriz Planelles, César Margarit, María-del-Mar Inda, et al.The Pharmacogenomics Journal 20 (2) 320 (2020)
https://doi.org/10.1038/s41397-019-0118-9
723 (2019)
https://doi.org/10.1002/9781119413431.ch29
Health benefits of an adverse events reporting system for chronic pain patients using long‐term opioids
Beatriz Planelles, César Margarit, Raquel Ajo, Yolanda Sastre, Javier Muriel, María‐del‐Mar Inda, María D. Esteban and Ana M. PeiróActa Anaesthesiologica Scandinavica 63 (2) 248 (2019)
https://doi.org/10.1111/aas.13243
Informativité des déclarations de pharmacovigilance en médecine générale en France
Xavier Humbert, Julien Jacquot, Joachim Alexandre, Marion Sassier, Ninon Robin, Cécile Pageot, Farid Kheloufi, Caroline Joyau, Antoine Coquerel, Geneviève Durrieu and Sophie FedrizziSanté Publique Vol. 31 (4) 561 (2019)
https://doi.org/10.3917/spub.194.0561
The Quality of Spontaneous Adverse Drug Reaction Reports in China: A Descriptive Study
Yue Chen, Rui Niu, Yufang Xiang, et al.Biological and Pharmaceutical Bulletin 42 (12) 2083 (2019)
https://doi.org/10.1248/bpb.b19-00637
Évaluation d’un nouvel outil en pharmacovigilance : la déclaration simplifiée en ligne pour les médecins généralistes
Xavier Humbert, Basile Chrétien, Marion Sassier, Antoine Coquerel, Joachim Alexandre and Sophie FedrizziSanté Publique Vol. 30 (2) 225 (2018)
https://doi.org/10.3917/spub.182.0225
En route to precision medicine through the integration of biological sex into pharmacogenomics
Lea Gaignebet and Georgios KararigasClinical Science 131 (4) 329 (2017)
https://doi.org/10.1042/CS20160379
Consensus-based recommendations for case report in Chinese medicine (CARC)
Shu-fei Fu, Chung-wah Cheng, Li Zhang, et al.Chinese Journal of Integrative Medicine 22 (1) 73 (2016)
https://doi.org/10.1007/s11655-015-2121-6
Hypersensitivity Reactions, Dietary Supplements, and the Importance of the Case Report
Kimberly G. Blumenthal and John B. ZieglerThe Journal of Allergy and Clinical Immunology: In Practice 4 (1) 177 (2016)
https://doi.org/10.1016/j.jaip.2015.08.001
Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study
Geneviève Durrieu, Julien Jacquot, Mathilde Mège, et al.Drug Safety 39 (12) 1189 (2016)
https://doi.org/10.1007/s40264-016-0463-4
Treatment of Congenital Toxoplasmosis
Julie Teil, Damien Dupont, Bruno Charpiat, et al.The Pediatric Infectious Disease Journal 35 (6) 634 (2016)
https://doi.org/10.1097/INF.0000000000001120
Bullous pemphigoid induced by m‐TOR inhibitors in renal transplant recipients
L. Atzori, B. Conti, M. Zucca and M. PauJournal of the European Academy of Dermatology and Venereology 29 (8) 1626 (2015)
https://doi.org/10.1111/jdv.12662
Feasibility and Safety of Cardiopulmonary Exercise Testing in Multiple Sclerosis: A Systematic Review
Lizanne Eva van den Akker, Martin Heine, Nikki van der Veldt, et al.Archives of Physical Medicine and Rehabilitation 96 (11) 2055 (2015)
https://doi.org/10.1016/j.apmr.2015.04.021
Toward standardized reporting of drug interactions: the READI checklist for anecdotal reports
Jeffrey K AronsonExpert Review of Clinical Pharmacology 8 (4) 399 (2015)
https://doi.org/10.1586/17512433.2015.1049598
121 (2014)
https://doi.org/10.1002/9781118820186.ch10
The Quality of Reports on Cervical Arterial Dissection following Cervical Spinal Manipulation
Shari Wynd, Michael Westaway, Sunita Vohra, Greg Kawchuk and Jean-Claude BaronPLoS ONE 8 (3) e59170 (2013)
https://doi.org/10.1371/journal.pone.0059170
Review article: Reporting Guidelines in the biomedical literature
James D. O’Leary and Mark W. CrawfordCanadian Journal of Anesthesia/Journal canadien d'anesthésie 60 (8) 813 (2013)
https://doi.org/10.1007/s12630-013-9973-z
581 (2012)
https://doi.org/10.1002/9781119959946.ch33
Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl
Claudia Della Corte, Antonio Carlucci, Paola Francalanci, Anna Alisi and Valerio NobiliVaccine 29 (29-30) 4654 (2011)
https://doi.org/10.1016/j.vaccine.2011.05.002
699 (2011)
https://doi.org/10.1002/9780470975053.app2
1 (2011)
https://doi.org/10.1002/9780470975053.ch1
Case Series in Drug Safety
Claire Nour Abou Chakra, Antoine Pariente, Marion Pinet, et al.Drug Safety 33 (12) 1081 (2010)
https://doi.org/10.2165/11539300-000000000-00000
Recent Publications on Medications and Pharmacy
Jacyntha A. SterlingHospital Pharmacy 44 (12) 1149 (2009)
https://doi.org/10.1310/hpj4412-1149